Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial
Despite urgent warnings about the spread of multidrug-resistant bacteria, the antibiotic development pipeline has remained sparsely populated. Naturally occurring antibacterial compounds may provide novel chemical starting points for antibiotic development programs and should be actively sought out....
Main Authors: | Nicola Ooi, Ian R. Cooper, Brendan Norman, James A. Gallagher, Nick Sireau, George Bou-Gharios, Lakshminarayan R. Ranganath, Victoria J. Savage |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/13/1683 |
Similar Items
-
Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-01-01) -
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-09-01) -
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-08-01) -
Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria
by: L.R. Ranganath, et al.
Published: (2022-03-01) -
Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
by: Mohammad S. Z. Ahmad, et al.
Published: (2022-07-01)